MedTrace Logo

Impact of Treatment With ALVEOGYL in Patients With Post-extraction Dry Socket

NCT05536115 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2026-05-14

Study results available
· View outcomes & findings →

Summary

Alveogyl (Septodont, Saint-Maur-des-Fossés - France) is a Medical Device used as dressing in case of dry socket.

ALVE study is a clinical investigation measuring Alveogyl performance and safety in patients with post-extraction dry socket.

The study takes place in India and in France where Alveogyl is already marketed, since 2010 in France and since 2014 in India .

Conditions

  • Dry Socket

Interventions

DEVICE

Alveogyl

The patients will be treated by Alveogyl. Global treatment protocol (curettage, cleaning, local anaesthesia etc.) of the dry socket is at the discretion of the Investigator. Alveogyl is used as an alveolar dressing. Placement of Alveogyl (about 0.2 g of paste) into the dental socket is done according to its instruction for use by a dental professional only.

Sponsors & Collaborators

  • SMO Clinical Research

    collaborator UNKNOWN

  • QualityStat

    collaborator UNKNOWN

  • Septodont

    lead INDUSTRY

Principal Investigators

  • Géraldine Lescaille, DDS, PhD · Odontology department - Pitié-Salpêtrière Hospital

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-13
Primary Completion
2025-06-26
Completion
2025-06-26

Countries

  • France
  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05536115 on ClinicalTrials.gov